| Identification | Back Directory | [Name]
1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) | [CAS]
1185726-51-5 | [Synonyms]
1H-Benzimidazole, 2-[2-(2-furanyl)ethenyl]-1-(2-propen-1-yl)-, hydrochloride (1:1) | [Molecular Formula]
C16H15ClN2O | [MOL File]
1185726-51-5.mol | [Molecular Weight]
286.76 |
| Hazard Information | Back Directory | [Uses]
CDKI-IN-1 (Compound SNX12) is a cyclin-dependent kinase inhibitor (CDKI) inhibitor that can be used for research into degenerative diseases of the central nervous system[1]. | [References]
[1] Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent, US20090281129. 2009-11-12. |
|
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|